Biogen’s Alzheimer’s Drug Shows Promising Test Results - What Analysts Think

Biogen presented test results for BIIB037, a drug intended to treat Alzheimer’s disease, on March 20. Here's how stock analysts have reacted to the news.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.